Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro diagnostic
Read moreDesarrollado por el BDSLab ITACA, puede identificar distintos patrones de crecimiento tumoral y predecir de manera independiente la supervivencia de los pacientes
Read moreThe initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors
Read moreIt has been developed a simple model capable of predicting which patients suffering a first psychotic episode will recover during their first year of treatment.
Read moreExploran cómo los AbyPanels de Abylabel, kits que incluyen varios anticuerpos dirigidos contra un mismo target en volúmenes reducidos, permiten llevar a cabo esta validación de forma más eficiente...
Read moreParkinson’s disease is the second most common neurodegenerative disorder and affects more than 160,000 people in Spain, with an estimated prevalence of between 20,000 and 25,000 patients in Cataloni...
Read moreThe study, led by the Hospital del Mar Research Institute and IRB Barcelona, shows that the determination of this protein, CTHRC1, can be used to assess patient prognosis. At the same time, it opens u...
Read moreValidan una tecnología basada en la respuesta inmunitaria para anticipar la evolución clínica en pacientes con sepsis atendidos en urgencias y en unidades de cuidados intensivos
Read moreThe search for safer, more effective medicines increasingly depends on understanding how biological systems respond to disease, genetic variation, and therapeutic interventions at the molecular level....
Read moreLa diabetes mellitus se asocia a un incremento significativo del riesgo cardiovascular, constituyendo la principal causa de morbimortalidad en estos pacientes. Además de la hiperglucemia crónica, ot...
Read moreThe biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.
Read moreEl proyecto, liderado por INCLIVA, el Hospital del Mar Research Institute y el Vall d’Hebron Instituto de Oncología, ha desarrollado modelos basados en inteligencia artificial y en el uso de la bio...
Read more